Keyphrases
Glioblastoma
100%
Formin
100%
Formin Protein
100%
INF2
90%
FHOD1
40%
Immunohistochemistry
20%
High-level Expression
20%
Knockdown
20%
Glioblastoma Cells
20%
MDia2
20%
MDia1
20%
Quantitative PCR
10%
Future Therapeutics
10%
Tissue Sampling
10%
Therapeutic Target
10%
Prognostic Value
10%
Follow-up Data
10%
Worse Outcome
10%
Actin
10%
Cellular Processes
10%
Transcriptome Analysis
10%
Primary Glioblastoma
10%
Commercially Available
10%
Motility
10%
Cell Migration
10%
SiRNA Knockdown
10%
Anticancer Therapy
10%
Cytoskeleton
10%
Invasive Behavior
10%
Molecular Regulators
10%
Cell Studies
10%
Glioblastoma Therapy
10%
Small Molecule Agonist
10%
Concurrent Search
10%
Glioblastoma Cell Lines
10%
IDH-mutant Glioma
10%
Migrating Cells
10%
Inhibiting Compounds
10%
Neuroscience
In Vitro
100%
Cell Line
66%
Immunohistochemistry
66%
Behavior (Neuroscience)
33%
Agonist
33%
Transcriptomics
33%
Actin
33%
Actin Cytoskeleton
33%
Cell Migration
33%
Small Interfering RNA
33%
Medicine and Dentistry
Glioblastoma
100%
Methenamine
100%
In Vitro
23%
Immunohistochemistry
15%
Actin
15%
Cell Line
7%
Cancer Treatment
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Gene Expression Profiling
7%
Small Interfering RNA
7%
Cell Migration
7%
Tumor Spheroid
7%
Cytoskeleton
7%
Glioblastoma Cell Line
7%
Biochemistry, Genetics and Molecular Biology
Formins
100%
INF2
69%
Actin
15%
MDia1
15%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Gene Expression Profiling
7%
Cell Migration
7%
Small Molecule
7%
Agonist
7%
Small Interfering RNA
7%
Cytoskeleton
7%
Tumor Spheroid
7%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Methenamine
100%
Actin
15%
Malignant Neoplasm
7%
Small Interfering RNA
7%
Cellular Processes
7%